Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study-Reference-Cited by-同舟云学术

Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study

Published:2016-07 Issue:1 Volume:223 Page:52-65
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Bergquist John R.,Puig Carlos A.,Shubert Christopher R.,Groeschl Ryan T.,Habermann Elizabeth B.,Kendrick Michael L.,Nagorney David M.,Smoot Rory L.,Farnell Michael B.,Truty Mark J.

Funder

Mayo Clinic

Publisher

Elsevier BV

Subject

Surgery

Reference67 articles.

1. Cancer burden in the year 2000. The global picture;Parkin;Eur J Cancer,2001

2. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

3. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma;Wagner;Br J Surg,2004

4. National failure to operate on early stage pancreatic cancer;Bilimoria;Ann Surg,2007

5. Treatment of borderline resectable pancreatic cancer;Cooper;Curr Treat Options Oncol,2013

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma;HPB;2024-06

2. Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis;Annals of Surgical Oncology;2024-05-06

3. CA19-9 Benefits Prognostication of Pancreatic Cancer: Is It Time to Add CA19-9 to Its Staging Criteria?;Annals of Surgical Oncology;2024-05-06

4. Multimodal Approaches to Patient Selection for Pancreas Cancer Surgery;Current Oncology;2024-04-15

5. Response to: Comment on “Dynamics of Serum CA 19-9 in Patients Undergoing Pancreatic Cancer Resection”;Annals of Surgery Open;2024-03-26